Buyers should qualify a food-contact plasticizer only when the exact substance, authorization route, intended article, and use conditions are aligned; finished-article migration evidence covers the commercial formulation and worst foreseeable contact; and representative commercial lots meet controlled impurity and consistency requirements. FDA’s 2026 review is not a ban or blanket reapproval. It proposes cumulative grouping for DEHP, DCHP, DIOP, and DINP, while all eight authorized plasticizers remain under post-market review. Therefore, a COA, an “FDA compliant” letter, a non-detect result, or a successful development sample is preliminary evidence—not sufficient supplier approval.

What Does FDA’s 2026 Review Change for Supplier Approval?

On May 27, 2026, FDA published a scientific evaluation of eight ortho-phthalates currently authorized as food-contact plasticizers. The agency proposed treating four—DEHP, DCHP, DIOP, and DINP—as chemically or pharmacologically related substances for a future cumulative risk assessment.

The review does not itself revoke an authorization, establish a new migration limit, or prove that the other four substances have been cleared. It increases the importance of documenting actual uses, use levels, migration, dietary exposure, and supplier controls. FDA’s current position and review status are summarized on its official page covering phthalates in food packaging and food-contact applications.

For supplier approval, the immediate question is not simply, “Is this phthalate still listed?” It is:

Does the cited authorization cover this exact substance in this exact polymer, article, food category, plasticizer loading, temperature, and contact duration?

Which FDA Authorization Must the Supplier Demonstrate?

The following screening map is based on FDA’s current inventory of phthalates listed in 21 CFR. A CFR citation identifies a regulatory route to investigate; it does not mean every use of that substance is permitted.

A supplier declaration should state the exact section relied upon and map each limitation to the customer’s application. A document that lists several CFR sections without identifying the applicable one should remain an unresolved regulatory gap.

If an alternative plasticizer relies on a Food Contact Notification rather than a generally applicable regulation, the buyer must also confirm that the exact manufacturer or supplier is named in the effective FCN. FCN coverage cannot normally be transferred to an unlisted second source.

Which Parameters Affect Plasticizer Qualification?

Plasticizer qualification requires more than comparing assay values. The approved specification must connect raw-material variation with processing, finished-article performance, and migration risk.

Density, refractive index, appearance, and color can support identity or consistency checks, but they cannot replace a composition or impurity method. Similarly, a high assay result does not establish low migration from the finished article.

What Can Migration Testing Confirm?

A suitable migration study can support approval when it measures defined substances migrating from a representative finished article under intended or technically justified worst-case conditions.

The study should identify:

• Polymer and complete relevant formulation
• Plasticizer loading and specification range
• Article type, thickness, and food-contact area
• Food or food simulant
• Contact temperature and duration
• Single-use or repeated-use conditions
• Target analytes and relevant impurities
• Extraction and analytical method
• Calibration, blanks, recovery, LOQ, and measurement uncertainty
• Units and assumptions used for exposure calculations

FDA’s Chemistry Recommendations for food-contact submissions provide the official framework for connecting chemical identity, intended use, migration, and dietary exposure.

A result can support the intended application only when the study conditions are equal to or more severe than the commercial use. A room-temperature aqueous-food study should not be extended automatically to hot-fill, sterilization, fatty-food, alcoholic-food, or long-term storage applications.

What Can Migration Testing Not Confirm?

Migration testing cannot independently prove:

• That the substance has a valid regulatory authorization
• Suitability for untested foods or contact conditions
• Performance of a different formulation, loading, or article thickness
• Consistency across future commercial batches
• Absence of compounds outside the analytical target list
• Toxicological safety without an exposure-based assessment
• Equivalence of another manufacturing source

“Not detected” means only that the named analyte was not detected above the disclosed method capability in the tested specimen. An ND result should not support approval when the report omits the analyte list, LOQ, recovery, blank correction, or test conditions.

Testing a neat plasticizer or raw-material extract also cannot replace migration testing on the finished food-contact article. Polymer type, stabilizers, fillers, processing history, thickness, and plasticizer loading can all change migration behavior.

When Is a COA Not Enough?

A batch-specific COA can support:

• Preliminary quality screening
• Confirmation of batch number and manufacturing date
• Comparison with the agreed raw-material specification
• Review of approval-critical parameters
• Traceability during a deviation investigation

A COA cannot, by itself, prove:

• Long-term storage stability
• Performance in the customer’s polymer formulation
• Finished-article migration
• Scale-up consistency
• Representativeness of future commercial batches
• Regulatory suitability for the intended use
• Control of undeclared or untested contaminants

The buyer should confirm that each critical COA result uses an identified method and that supplier results are analytically comparable with internal or third-party data. A generic COA without an actual batch number or numerical results should not support approval.

ChemicalCell’s overview of COA, SDS, TDS, and raw-material compliance evidence can support the initial document review, but food-contact plasticizer approval still requires use-specific regulatory and migration evidence.

How Should a Sample Move to Commercial Approval?

Supplier approval should use staged decisions rather than treating a successful development sample as a commercial qualification.

Development and commercial material may differ because of:

• Pilot versus full-scale reaction and purification
• Wider commercial specification ranges
• Lot-to-lot feedstock variation
• Different drums, liners, tanks, or hoses
• Longer transportation and storage
• Sample selection from a non-representative batch

Before full approval, representative commercial lots should be tested against approval-critical parameters. The finished article should also be produced under normal commercial processing conditions, not only laboratory compounding conditions.

How Should a Second Source Be Qualified?

The same chemical name or CAS number does not establish second-source equivalence.

Existing data may support a limited bridge only when:

1. Both sources have an independently valid regulatory basis for the intended use.
2. Identity, composition, critical impurities, and specification ranges are analytically comparable.
3. The customer formulation, loading, article geometry, and conditions of use remain unchanged.
4. The previous migration method remains capable of detecting risks introduced by the new source.
5. Representative commercial lots from the second source meet the approved control range.
6. The new supplier accepts equivalent change-notification and traceability obligations.

If the second source has a different synthesis route, feedstock, manufacturing site, impurity profile, packaging system, or authorization pathway, the original supplier’s migration and qualification evidence should not be transferred automatically.

Potential alternatives can be identified through ChemicalCell’s plastic and rubber additives portfolio, but no material should enter food-contact approval based only on a “non-phthalate,” “bio-based,” or “low-migration” description. The exact grade must pass the same regulatory, specification, sample, commercial-lot, and finished-article review.

When Is Supplier Requalification Required?

Requalification should be triggered when a change can affect identity, impurities, migration, exposure, or the approved use window, including:

• Manufacturing site or legal manufacturer change
• Feedstock, synthesis route, catalyst, or purification change
• New grade, composition, or specification limit
• Change in impurity or phthalate-testing method
• Higher plasticizer loading
• New polymer, article construction, or thickness
• New food category, temperature, or contact duration
• Change from single-use to repeated-use contact
• New drum, liner, hose, or bulk transfer system
• Significant deviation, contamination event, or migration failure
• Revised FDA assessment or authorization
• Second-source introduction

Not every document revision requires full migration testing. The supplier should disclose what changed, and the buyer should determine which parts of the regulatory, analytical, application, and commercial-batch evidence are affected.

What Should Buyers Submit for Technical Review or RFQ?

Before requesting a specification review, sample, or supplier comparison, provide:

• Plasticizer name, CAS number, and current or proposed supplier status
• Whether the project is a new qualification, replacement, or second source
• Polymer, finished article, plasticizer loading, and article thickness
• Food types and maximum contact time and temperature
• Single-use or repeated-use conditions
• Target U.S. authorization route
• Required impurity and targeted-phthalate limits
• Available migration protocol or customer test requirements
• Sample quantity, commercial volume, and packaging requirements
• Required COA, TDS, SDS, regulatory, traceability, and change-control documents

Submit these details through ChemicalCell’s chemical raw-material RFQ form. The appropriate next step is to compare the proposed specification and regulatory basis first, then request a representative sample, define finished-article testing, and establish commercial-lot and change-control requirements before supplier approval.